Canada Contrast Media Market Size, Share, & Trends Analysis Report: By Modality, By Product, By Application, By Route of Administration, By End Use (Hospital, Private Clinics, and Others) – Market Forecast, 2025–2034

The canada contrast media market size is expected to reach USD 375.31 million by 2034, according to a new study by Polaris Market Research. The report “Canada Contrast Media Market Size, Share, & Industry Analysis Report: By Modality, By Product, By Application, By Route of Administration, By End Use (Hospital, Private Clinics, and Others) – Market Forecast, 2025–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

Contrast media are substances used in medical imaging to enhance the visibility of internal structures such as blood vessels, organs, or tissues on scans such as X-rays, CTs, and MRIs.

Canada’s universal healthcare system ensures that all residents have access to medically necessary services, including diagnostic imaging. This broad access allows more people to undergo MRI and CT scans without worrying about high out-of-pocket costs. Since these scans often require contrast media to be effective, the public healthcare system helps maintain a strong demand for these products. The system also supports equal access across regions, ensuring that both large hospitals and smaller community clinics use contrast agents, contributing to the growth of the Canada contrast media market.

Canada is home to several leading research institutions and universities that actively collaborate with the medical imaging and pharmaceutical industries. These partnerships lead to innovations in contrast agent technology, such as safer formulations or agents tailored for specific imaging needs. Canadian companies and academic centers are further involved in clinical trials and product development, helping bring new solutions to the market. These technological advancements contribute to market growth by encouraging the use of newer products as they improve and become more widely adopted, thereby driving market growth.

Canada Contrast Media Market Report Highlights

In 2024, the iodinated segment dominated the Canada contrast media market due to its widespread use in CT scans, which are among the most commonly performed diagnostic imaging procedures in Canada.

The ultrasound segment is expected to witness the fastest growth during the forecast period, driven by the increasing use of contrast-enhanced ultrasound (CEUS) for real-time imaging of organs.

A few global key market players are Bayer AG, GE HealthCare, Guerbet, Lantheus, Bracco, Voyageur Pharmaceuticals Ltd, Grupo Juste, Franz Köhler Chemie GmbH, and MEDTRON AG.

Polaris Market Research has segmented the Canada contrast media market report on the basis of modality, product, application, route of administration, and end use:

By Modality (Revenue USD Million, 2020–2034)

Ultrasound

Magnetic Resonance Imaging

X-ray/Computed Tomography

By Product (Revenue USD Million, 2020–2034)

Microbubble

Gadolinium-Based

Iodinated

Iodixanol

Iohexol

Iopamidol

Others

Barium-Based

By Application (Revenue USD Million, 2020–2034)

Cardiovascular Disorders

Neurological Disorders

Gastrointestinal Disorders

Cancer

Nephrological Disorders

Musculoskeletal Disorders

Others

By Route of Administration (Revenue USD Million, 2020–2034)

Intravenous

Oral Route

Rectal Route

By End Use (Revenue USD Million, 2020–2034)

Hospitals

Private Clinics

Others


1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
2.1. Market Highlights
3. Research Methodology
3.1. Overview
3.1.1. Data Mining
3.2. Data Sources
3.2.1. Primary Sources
3.2.2. Secondary Sources
4. Canada Contrast Media Market Insights
4.1. Canada Contrast Media Market – Market Snapshot
4.2. Canada Contrast Media Market Dynamics
4.2.1. Drivers and Opportunities
4.2.1.1. Rising Elderly Population
4.2.1.2. Rising Cases of Chronic Disease
4.2.2. Restraints and Challenges
4.2.2.1. High Initial Investment
4.3. Porter’s Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Canada Contrast Media Market Trends
4.6. Value Chain Analysis
5. Canada Contrast Media Market, by Modality
5.1. Key Findings
5.2. Introduction
5.2.1. Canada Contrast Media Market, by Modality, 2020-2034 (USD million)
5.3. Ultrasound
5.3.1. Canada Contrast Media Market, by Ultrasound, 2020–2034 (USD million)
5.4. Magnetic Resonance Imaging
5.4.1. Canada Contrast Media Market, by Magnetic Resonance Imaging, 2020–2034 (USD million)
5.5. X-ray/Computed Tomography
5.5.1. Canada Contrast Media Market, by X-ray/Computed Tomography, 2020–2034 (USD million)
6. Canada Contrast Media Market, by Product
6.1. Key Findings
6.2. Introduction
6.2.1. Canada Contrast Media Market, by Product, 2020-2034 (USD million)
6.3. Microbubble
6.3.1. Canada Contrast Media Market, by Microbubble, 2020–2034 (USD million)
6.4. Gadolinium-Based
6.4.1. Canada Contrast Media Market, by Gadolinium-Based, 2020–2034 (USD million)
6.5. Iodinated
6.5.1. Canada Contrast Media Market, by Iodinated, 2020–2034 (USD million)
6.5.2. Iodixanol
6.5.2.1. Canada Contrast Media Market, by Iodixanol, 2020–2034 (USD million)
6.5.3. Iohexol
6.5.3.1. Canada Contrast Media Market, by Iohexol, 2020–2034 (USD million)
6.5.4. Iopamidol
6.5.4.1. Canada Contrast Media Market, by Iopamidol, 2020–2034 (USD million)
6.5.5. Others
6.5.5.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
6.6. Barium-Based
6.6.1. Canada Contrast Media Market, by Barium-Based, 2020–2034 (USD million)
7. Canada Contrast Media Market, by Application
7.1. Key Findings
7.2. Introduction
7.2.1. Canada Contrast Media Market, by Medical Biotechnology, 2020-2034 (USD million)
7.3. Cardiovascular Disorders
7.3.1. Canada Contrast Media Market, by Cardiovascular Disorders, 2020–2034 (USD million)
7.4. Neurological Disorders
7.4.1. Canada Contrast Media Market, by Neurological Disorders, 2020–2034 (USD million)
7.5. Gastrointestinal Disorders
7.5.1. Canada Contrast Media Market, by Gastrointestinal Disorders, 2020–2034 (USD million)
7.6. Cancer
7.6.1. Canada Contrast Media Market, by Cancer, 2020–2034 (USD million)
7.7. Nephrological Disorders
7.7.1. Canada Contrast Media Market, by Nephrological Disorders, 2020–2034 (USD million)
7.8. Musculoskeletal Disorders
7.8.1. Canada Contrast Media Market, by Musculoskeletal Disorders, 2020–2034 (USD million)
7.9. Others
7.9.1. Canada Contrast Media Market, by Others, 2020–2034 (USD million)
8. Canada Contrast Media Market, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
8.3. Intravenous
8.3.1. Canada Contrast Media Market, by Intravenous, 2020–2034 (USD million)
8.4. Oral Route
8.4.1. Canada Contrast Media Market, by Oral Route, 2020–2034 (USD million)
8.5. Rectal Route
8.5.1. Canada Contrast Media Market, by Rectal Route, 2020–2034 (USD million)
9. Canada Contrast Media Market, by End Use
9.1. Key Findings
9.2. Introduction
9.2.1. Canada Contrast Media Market, by Route of Administration, 2020-2034 (USD million)
9.3. Hospitals
9.3.1. Canada Contrast Media Market, by Hospitals, 2020–2034 (USD million)
9.4. Private Clinics
9.4.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
9.5. Others
9.5.1. Canada Contrast Media Market, by Private Clinics, 2020–2034 (USD million)
10. Competitive Landscape
10.1. Expansion and Acquisition Analysis
10.1.1. Expansion
10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Product Benchmarking
11.1.4. Recent Development
11.2. Bracco
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Product Benchmarking
11.2.4. Recent Development
11.3. Dr. Franz Köhler Chemie GmbH
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Product Benchmarking
11.3.4. Recent Development
11.4. GE HealthCare
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Product Benchmarking
11.4.4. Recent Development
11.5. Grupo Juste
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Product Benchmarking
11.5.4. Recent Development
11.6. Guerbet
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Product Benchmarking
11.6.4. Recent Development
11.7. Lantheus
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Product Benchmarking
11.7.4. Recent Development
11.8. MEDTRON AG
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Product Benchmarking
11.8.4. Recent Development
11.9. Voyageur Pharmaceuticals Ltd
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Product Benchmarking
11.9.4. Recent Development

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings